dr perlmutter parkinson's glutathione named scientific director of dystonia foundation – WashU Medicine Promising biomarkers and therapeutic targets
Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research Metabolic Brain Disease Springer Nature Link David Perlmutter, M.D. (@DavidPerlmutterMd) Facebook Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits Rabin 2015 Movement Disorders Clinical Practice Wiley Online Library New book explores brain's immune system and neurodegenerative disease prevention Julia Perlmutter Samton Independent Doctors of New York
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10


